FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4306291497> ?p ?o ?g. }

• W4306291497 abstract "Abstract Background Tissue damage due to acute myocardial infarction is caused by both the ischemic insult and subsequent reperfusion injury (I/R). Restoration of coronary blood flow accelerates cardiomyocyte death, a phenomenon referred to as reperfusion injury, the extent of which is partly modulated by cardiac progenitor cells (CPC). Development of novel therapies to reduce infarct size, the main determinant of outcome, represent a huge unmet medical need (1). Systemic levels of growth differentiation factor 11 (GDF11), a TGF-β superfamily member that shares 90% homology with myostatin, decline with age, and GDF11 replenishment by heterochronic parabiosis or systemic recombinant GDF11 (rGDF11) delivery was postulated to have rejuvenating effects (2). Purpose We aimed to probe the effects of systemic GDF11 replenishment on I/R injury and deepen insights into the molecular mechanisms involved. Methods We designed a vehicle-controlled study in which young (3–4 months) and old (22–24 months) C57Bl/6 mice were randomly assigned to either daily systemic rGDF11 or control treatment over 30 days before myocardial I/R injury was induced. Dissected hearts were subjected to in-depth profiling followed by IPA-guided -omics to identify key regulatory mechanisms. Finally, in vitro experiments on human CPCs and HL-1 cardiomyocytes were performed. Results Myocardial Gdf11 expression declined with age, whereas myostatin (Mstn) showed an opposing expression pattern (Fig. 1A), a trend similarly observed upon I/R (Fig. 1B). Surprisingly, after the 30-day study period (Fig. 1C), young and aged rGDF11-treated mice showed higher I/R-induced infarct size and serum cardiac troponin I levels than controls, despite comparable areas at risk (Fig. 1D). Importantly, while proxies of necroptosis/pyroptosis remained unchanged, rGDF11-treated animals showed reduced cardiomyocyte viability irrespective of their age (Fig. 2A). Targeted transcriptomics applied on cardiac tissues of both groups identified the CPC-marker Nkx2–5 to be differentially regulated (Fig. 2B-C), an expression pattern validated in an independent cohort at both mRNA and protein levels (Fig. 2D). In the adult myocardium, the expression of both Nkx2–5 and its cofactor Gata4 is mainly confined to CPCs; indeed, similar reductions in Nkx2–5 and Gata4 expression were observed in CPCs exposed to rGDF11 (Fig. 2E) which coincided with accelerated cardiomyocyte death if cultured in conditioned media obtained from CPCs treated with rGDF11 (Fig. 2F), pointing toward a paracrine signalling pathway. Conclusions Myocardial expression of GDF11 declines with age, and is blunted upon I/R injury, thereby opposing the expression pattern of myostatin. Surprisingly, however, systemic GDF11 replenishment by rGDF11 supplementation enhances rather than reduces myocardial infarct size through augmented apoptosis, a phenomenon mediated by diminished cardioprotective function of CPCs. Funding Acknowledgement Type of funding sources: Foundation. Main funding source(s): Foundation for Cardiovascular Research – Zurich Heart House" @default.
• W4306291497 created "2022-10-15" @default.
• W4306291497 creator A5005949578 @default.
• W4306291497 creator A5011650709 @default.
• W4306291497 creator A5015038643 @default.
• W4306291497 creator A5031442314 @default.
• W4306291497 creator A5032257383 @default.
• W4306291497 creator A5037211974 @default.
• W4306291497 creator A5041969518 @default.
• W4306291497 creator A5050799541 @default.
• W4306291497 creator A5056252884 @default.
• W4306291497 creator A5067387423 @default.
• W4306291497 creator A5068122044 @default.
• W4306291497 creator A5082098431 @default.
• W4306291497 creator A5084708009 @default.
• W4306291497 creator A5085573148 @default.
• W4306291497 creator A5087014906 @default.
• W4306291497 date "2022-10-01" @default.
• W4306291497 modified "2023-09-29" @default.
• W4306291497 title "Systemic GDF11 replenishment ignites myocardial injury through diminishing anti-apoptotic activity of cardiac progenitor cells" @default.
• W4306291497 doi "https://doi.org/10.1093/eurheartj/ehac544.2915" @default.
• W4306291497 hasPublicationYear "2022" @default.
• W4306291497 type Work @default.
• W4306291497 citedByCount "0" @default.
• W4306291497 crossrefType "journal-article" @default.
• W4306291497 hasAuthorship W4306291497A5005949578 @default.
• W4306291497 hasAuthorship W4306291497A5011650709 @default.
• W4306291497 hasAuthorship W4306291497A5015038643 @default.
• W4306291497 hasAuthorship W4306291497A5031442314 @default.
• W4306291497 hasAuthorship W4306291497A5032257383 @default.
• W4306291497 hasAuthorship W4306291497A5037211974 @default.
• W4306291497 hasAuthorship W4306291497A5041969518 @default.
• W4306291497 hasAuthorship W4306291497A5050799541 @default.
• W4306291497 hasAuthorship W4306291497A5056252884 @default.
• W4306291497 hasAuthorship W4306291497A5067387423 @default.
• W4306291497 hasAuthorship W4306291497A5068122044 @default.
• W4306291497 hasAuthorship W4306291497A5082098431 @default.
• W4306291497 hasAuthorship W4306291497A5084708009 @default.
• W4306291497 hasAuthorship W4306291497A5085573148 @default.
• W4306291497 hasAuthorship W4306291497A5087014906 @default.
• W4306291497 hasBestOaLocation W43062914971 @default.
• W4306291497 hasConcept C126322002 @default.
• W4306291497 hasConcept C164705383 @default.
• W4306291497 hasConcept C167414201 @default.
• W4306291497 hasConcept C190283241 @default.
• W4306291497 hasConcept C201750760 @default.
• W4306291497 hasConcept C2777380497 @default.
• W4306291497 hasConcept C2777488582 @default.
• W4306291497 hasConcept C28328180 @default.
• W4306291497 hasConcept C500558357 @default.
• W4306291497 hasConcept C55493867 @default.
• W4306291497 hasConcept C71924100 @default.
• W4306291497 hasConcept C86803240 @default.
• W4306291497 hasConcept C95444343 @default.
• W4306291497 hasConceptScore W4306291497C126322002 @default.
• W4306291497 hasConceptScore W4306291497C164705383 @default.
• W4306291497 hasConceptScore W4306291497C167414201 @default.
• W4306291497 hasConceptScore W4306291497C190283241 @default.
• W4306291497 hasConceptScore W4306291497C201750760 @default.
• W4306291497 hasConceptScore W4306291497C2777380497 @default.
• W4306291497 hasConceptScore W4306291497C2777488582 @default.
• W4306291497 hasConceptScore W4306291497C28328180 @default.
• W4306291497 hasConceptScore W4306291497C500558357 @default.
• W4306291497 hasConceptScore W4306291497C55493867 @default.
• W4306291497 hasConceptScore W4306291497C71924100 @default.
• W4306291497 hasConceptScore W4306291497C86803240 @default.
• W4306291497 hasConceptScore W4306291497C95444343 @default.
• W4306291497 hasIssue "Supplement_2" @default.
• W4306291497 hasLocation W43062914971 @default.
• W4306291497 hasOpenAccess W4306291497 @default.
• W4306291497 hasPrimaryLocation W43062914971 @default.
• W4306291497 hasRelatedWork W1981654342 @default.
• W4306291497 hasRelatedWork W2023873491 @default.
• W4306291497 hasRelatedWork W2049397185 @default.
• W4306291497 hasRelatedWork W2062221236 @default.
• W4306291497 hasRelatedWork W2087313135 @default.
• W4306291497 hasRelatedWork W2120735623 @default.
• W4306291497 hasRelatedWork W2367140913 @default.
• W4306291497 hasRelatedWork W2399063111 @default.
• W4306291497 hasRelatedWork W2437485626 @default.
• W4306291497 hasRelatedWork W4306291497 @default.
• W4306291497 hasVolume "43" @default.
• W4306291497 isParatext "false" @default.
• W4306291497 isRetracted "false" @default.
• W4306291497 workType "article" @default.